Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Alcalá

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Clinical Hemorheology and Microcirculation|January 14, 2012
Rheological alterations and thrombotic events in patients with systemic lupus erythematosusAmparo Vayá, Javier Calvo, Carmen Alcalá, et al.
Journal of Neurology|January 21, 2019
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safeCarmen Alcalá, F Gascón, Francisco Pérez-Miralles, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 27, 2023
Eculizumab for a catastrophic relapse in NMOSD: case reportDavid Gorriz, Francisco Carlos Pérez-Miralles, Carlos Quintanilla-Bordás, et al.
Annals of Clinical and Translational Neurology|January 17, 2020
An expanded parenchymal CD8+ T cell clone in GABA<sub>A</sub> receptor encephalitisAline Bracher, Carmen Alcalá, Jaime Ferrer, et al.
Neuroradiology|November 4, 2011
Long-term outcome in patients with carotid artery stenting and contralateral carotid occlusion: a single neurovascular center prospective analysisAida Lago, Vera Parkhutik, Jose Ignacio Tembl, et al.
Journal of Neurology|May 23, 2018
Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based studyCarmen Alcalá, F Gascón, F Pérez-Miralles, et al.
Acta Neurologica Belgica|October 12, 2020
Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarksAntonio Barreiro-González, Maria T Sanz, Sara Carratalà-Boscà, et al.
European Neurology|November 17, 2021
Design and Validation of an Expanded Disability Status Scale Model in Multiple SclerosisAntonio Barreiro-González, Maria T Sanz, Sara Carratalà-Boscà, et al.
Journal of the Neurological Sciences|October 22, 2020
Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarksAntonio Barreiro-González, Maria T Sanz, Sara Carratalà-Boscà, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapiesFrancisco Coret, Francisco C Pérez-Miralles, Francisco Gascón, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Clinical Hemorheology and Microcirculation|January 14, 2012
Rheological alterations and thrombotic events in patients with systemic lupus erythematosusAmparo Vayá, Javier Calvo, Carmen Alcalá, et al.
Journal of Neurology|January 21, 2019
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safeCarmen Alcalá, F Gascón, Francisco Pérez-Miralles, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 27, 2023
Eculizumab for a catastrophic relapse in NMOSD: case reportDavid Gorriz, Francisco Carlos Pérez-Miralles, Carlos Quintanilla-Bordás, et al.
Annals of Clinical and Translational Neurology|January 17, 2020
An expanded parenchymal CD8+ T cell clone in GABA<sub>A</sub> receptor encephalitisAline Bracher, Carmen Alcalá, Jaime Ferrer, et al.
Neuroradiology|November 4, 2011
Long-term outcome in patients with carotid artery stenting and contralateral carotid occlusion: a single neurovascular center prospective analysisAida Lago, Vera Parkhutik, Jose Ignacio Tembl, et al.
Journal of Neurology|May 23, 2018
Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based studyCarmen Alcalá, F Gascón, F Pérez-Miralles, et al.
Acta Neurologica Belgica|October 12, 2020
Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarksAntonio Barreiro-González, Maria T Sanz, Sara Carratalà-Boscà, et al.
European Neurology|November 17, 2021
Design and Validation of an Expanded Disability Status Scale Model in Multiple SclerosisAntonio Barreiro-González, Maria T Sanz, Sara Carratalà-Boscà, et al.
Journal of the Neurological Sciences|October 22, 2020
Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarksAntonio Barreiro-González, Maria T Sanz, Sara Carratalà-Boscà, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 10, 2018
Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapiesFrancisco Coret, Francisco C Pérez-Miralles, Francisco Gascón, et al.
Pageof 4